文献速递传染病防控与疫情报告

用曼氏血吸虫肠道来源的半胱氨酸肽酶SmCB1和SmCL3免疫仓鼠可抵御埃及血吸虫感染

Protection against Schistosoma haematobium infection in hamsters by immunization with Schistosoma mansoni gut-derived cysteine peptidases, SmCB1 and SmCL3.
PubMed 文献 · Vaccine · 2017-11-06

在两个独立实验中,每组8只叙利亚仓鼠分别用0(对照)、20 µg SmCB1、20 µg SmCL3或10 µg SmCB1加10 µg SmCL3间隔三周免疫两次,八周后经皮感染100条埃及血吸虫尾蚴。攻击感染后第10天SmCB1和SmCL3诱导低抗体滴度和弱但极化的2型细胞因子应答;两种肽酶单独或联合均使攻击后虫负荷重复且高度显著降低(>70%,P < 0.02),并显著降低虫卵计数和活力。

要点

  • SmCB1和SmCL3单独或联合免疫均使仓鼠攻击后虫负荷降低>70%(P < 0.02)。
  • 免疫后第10天抗体滴度低,但出现弱而极化的2型细胞因子应答。
  • 两种肽酶免疫还显著降低虫卵计数和虫卵活力。

核心结论

  • 数据支持既往发现,表明曼氏血吸虫半胱氨酸肽酶SmCB1和SmCL3是无需佐剂的有效疫苗,可在小鼠和仓鼠中诱导针对曼氏血吸虫和埃及血吸虫的保护。

研究设计与样本

  • 在两个独立实验中,每个实验每组8只叙利亚仓鼠,分别用0(对照)、20 µg SmCB1、20 µg SmCL3或10 µg SmCB1加10 µg SmCL3间隔三周免疫两次,八周后经皮感染100条埃及血吸虫尾蚴。
  • 攻击感染后第10天评估体液和全血培养细胞因子应答,感染后12周检查寄生虫学参数。

主要发现

  • 攻击感染后第10天,SmCB1和SmCL3诱导低抗体滴度和弱但极化的2型细胞因子应答。
  • 两种半胱氨酸肽酶单独或联合均引起攻击后虫负荷重复且高度显著降低(>70%,P < 0.02)。
  • 两种半胱氨酸肽酶单独或联合均显著降低虫卵计数和虫卵活力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We examined the immunogenicity and protective potential of SmCB1 and SmCL3 cysteine peptidases, alone and in combination, in hamsters challenged with S. haematobium. For each of two independent experiments, eight Syrian hamsters were immunized twice with a three week-interval with 0 (controls), 20 µg SmCB1, 20 µg SmCL3, or 10 µg SmCB1 plus 10 µg SmCL3, and then percutaneously exposed eight weeks later to 100 S. haematobium cercariae. Hamsters from each group were assessed for humoral and whole blood culture cytokine responses on day 10 post challenge infection, and examined for parasitological parameters 12 weeks post infection. At day 10 post-infection we found that SmCB1 and SmCL3 elicited low antibody titres and weak but polarized cytokine type 2 responses. Nevertheless, both cysteine peptidases, alone or in combination, evoked reproducible and highly significant reduction in challenge worm burden (>70%, P < 0.02) as well as a significant reduction in worm egg counts and viability. The data support our previous findings and show that S. mansoni cysteine peptidases SmCB1 and SmCL3 are efficacious adjuvant-free vaccines that induce protection in mice and hamsters against both S. mansoni and S. haematobium.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tallima H, Abou El Dahab M, Kareem S, et al. Protection against Schistosoma haematobium infection in hamsters by immunization with Schistosoma mansoni gut-derived cysteine peptidases, SmCB1 and SmCL3. Vaccine. 2017. PMID: 29122387. doi:10.1016/j.vaccine.2017.10.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。